FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207196803> ?p ?o ?g. }

• W3207196803 endingPage "S1073" @default.
• W3207196803 startingPage "S1072" @default.
• W3207196803 abstract "Patients with stage 3 Non Small Cell lung Cancer (NSCLC) are a heterogeneous group. Recent National Lung Cancer Audit (NLCA) indicates a third of patients (36%) received no active treatment. We audited the treatment received by all stage III NSCLC patients treated between April 2014 and April 2017 at the Edinburgh Cancer Centre. Using this data, we hope to delineate patterns in our selection of treatment based on a patient’s performance status and co-morbidities, to better understand which patient groups may be more likely to receive sub-optimal treatment. 374 patients were identified via local cancer registry. Patients were then categorised by treatment modality, ECOG performance status (PS) and Charlson morbidity score (CMS). Radical treatment was defined as chemoradiotherapy, radical radiotherapy or surgery. 374 patients were identified: 190 males (50.8%) and 184 females (49.2%). 222 patients (59.36%) were aged ≥70yrs, with a median age of 71yrs (range 42-93yrs). Median follow-up period was 398 days (range: 0-2445 days). 105 patients (28.07%) had a CMS of ≥1. 118 patients (31.55%) had an adenocarcinoma tumour type, 117 patients (31.28%) had squamous histology, 35 patients (9.36%) had other NSCLC histology and 4 patients (1.07%) had non-lung cancer histology. Histology was unavailable for 100 patients (26.74%). Radical treatment was given to 200 patients - surgery (24 patients, 12%), chemoradiotherapy (99 patients, 49.5%) and radical radiotherapy (77 patients, 38.5%). Of those with a PS 0 (64 patients): 47 (73.44%) received radical treatment; 12 (18.75%) received non-radical treatment, and 5 (7.81%) did not receive any treatment. Of those with PS 1 (178 patients): 115 (64.61%) received radical treatment; 27 (15.17%) received non-radical treatment, and 36 (20.22%) did not receive any treatment. Of those with a PS 2 (112 patients): 37 (33.04%) received radical treatment; 29 (25.89%) received non-radical treatment, and 46 (41.07%) did not receive any treatment. 20 patients did not have a clear documentation of their PS – 18 of these did not receive any treatment. Of those with CMS 0 (269 patients): 152 (56.51%) received radical treatment; 56 (20.82%) received non-radical treatment, and 61 (22.68%) did not receive any treatment. Of those with CMS 1 (61 patients): 34 (55.74%) received radical treatment; 6 (9.84%) received non-radical treatment, and 21 (34.43%) did not receive any treatment. Of those with a CMS ≥2 (44 patients): 14 (31.82%) received radical treatment; 7 (15.91%) received non-radical treatment, and 23 (52.27%) did not receive any treatment. Those with a better PS and CMS were more likely to receive treatment with radical intent. Those with a higher CMS were far more likely to receive no treatment or non-radical treatment. These patients may benefit from prehabilitation prior to treatment, to allow provision of life prolonging therapy to a greater cohort." @default.
• W3207196803 created "2021-10-25" @default.
• W3207196803 creator A5000983072 @default.
• W3207196803 creator A5001361998 @default.
• W3207196803 creator A5003618122 @default.
• W3207196803 creator A5017695061 @default.
• W3207196803 creator A5019431269 @default.
• W3207196803 creator A5024855544 @default.
• W3207196803 creator A5025172933 @default.
• W3207196803 creator A5043020536 @default.
• W3207196803 creator A5044530886 @default.
• W3207196803 creator A5051813018 @default.
• W3207196803 creator A5051927640 @default.
• W3207196803 creator A5059621255 @default.
• W3207196803 creator A5074809942 @default.
• W3207196803 date "2021-10-01" @default.
• W3207196803 modified "2023-10-01" @default.
• W3207196803 title "P40.09 Using Real World Data to Identify a Patient Cohort Who Require Prehabilitation to Improve Treatment Rates for Stage 3 NSCLC" @default.
• W3207196803 doi "https://doi.org/10.1016/j.jtho.2021.08.446" @default.
• W3207196803 hasPublicationYear "2021" @default.
• W3207196803 type Work @default.
• W3207196803 sameAs 3207196803 @default.
• W3207196803 citedByCount "0" @default.
• W3207196803 crossrefType "journal-article" @default.
• W3207196803 hasAuthorship W3207196803A5000983072 @default.
• W3207196803 hasAuthorship W3207196803A5001361998 @default.
• W3207196803 hasAuthorship W3207196803A5003618122 @default.
• W3207196803 hasAuthorship W3207196803A5017695061 @default.
• W3207196803 hasAuthorship W3207196803A5019431269 @default.
• W3207196803 hasAuthorship W3207196803A5024855544 @default.
• W3207196803 hasAuthorship W3207196803A5025172933 @default.
• W3207196803 hasAuthorship W3207196803A5043020536 @default.
• W3207196803 hasAuthorship W3207196803A5044530886 @default.
• W3207196803 hasAuthorship W3207196803A5051813018 @default.
• W3207196803 hasAuthorship W3207196803A5051927640 @default.
• W3207196803 hasAuthorship W3207196803A5059621255 @default.
• W3207196803 hasAuthorship W3207196803A5074809942 @default.
• W3207196803 hasBestOaLocation W32071968031 @default.
• W3207196803 hasConcept C121608353 @default.
• W3207196803 hasConcept C126322002 @default.
• W3207196803 hasConcept C141071460 @default.
• W3207196803 hasConcept C143998085 @default.
• W3207196803 hasConcept C146357865 @default.
• W3207196803 hasConcept C151730666 @default.
• W3207196803 hasConcept C2776256026 @default.
• W3207196803 hasConcept C2776874909 @default.
• W3207196803 hasConcept C2776907518 @default.
• W3207196803 hasConcept C2778424827 @default.
• W3207196803 hasConcept C2780258809 @default.
• W3207196803 hasConcept C2781182431 @default.
• W3207196803 hasConcept C509974204 @default.
• W3207196803 hasConcept C57742111 @default.
• W3207196803 hasConcept C71924100 @default.
• W3207196803 hasConcept C86803240 @default.
• W3207196803 hasConceptScore W3207196803C121608353 @default.
• W3207196803 hasConceptScore W3207196803C126322002 @default.
• W3207196803 hasConceptScore W3207196803C141071460 @default.
• W3207196803 hasConceptScore W3207196803C143998085 @default.
• W3207196803 hasConceptScore W3207196803C146357865 @default.
• W3207196803 hasConceptScore W3207196803C151730666 @default.
• W3207196803 hasConceptScore W3207196803C2776256026 @default.
• W3207196803 hasConceptScore W3207196803C2776874909 @default.
• W3207196803 hasConceptScore W3207196803C2776907518 @default.
• W3207196803 hasConceptScore W3207196803C2778424827 @default.
• W3207196803 hasConceptScore W3207196803C2780258809 @default.
• W3207196803 hasConceptScore W3207196803C2781182431 @default.
• W3207196803 hasConceptScore W3207196803C509974204 @default.
• W3207196803 hasConceptScore W3207196803C57742111 @default.
• W3207196803 hasConceptScore W3207196803C71924100 @default.
• W3207196803 hasConceptScore W3207196803C86803240 @default.
• W3207196803 hasIssue "10" @default.
• W3207196803 hasLocation W32071968031 @default.
• W3207196803 hasOpenAccess W3207196803 @default.
• W3207196803 hasPrimaryLocation W32071968031 @default.
• W3207196803 hasRelatedWork W2050954759 @default.
• W3207196803 hasRelatedWork W2056002207 @default.
• W3207196803 hasRelatedWork W2277416945 @default.
• W3207196803 hasRelatedWork W2329182818 @default.
• W3207196803 hasRelatedWork W2364422672 @default.
• W3207196803 hasRelatedWork W2387790385 @default.
• W3207196803 hasRelatedWork W2397916166 @default.
• W3207196803 hasRelatedWork W2743740828 @default.
• W3207196803 hasRelatedWork W2184311402 @default.
• W3207196803 hasRelatedWork W2288642166 @default.
• W3207196803 hasVolume "16" @default.
• W3207196803 isParatext "false" @default.
• W3207196803 isRetracted "false" @default.
• W3207196803 magId "3207196803" @default.
• W3207196803 workType "article" @default.